nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—ALB—atherosclerosis	0.241	1	CbGaD
Fosphenytoin—ALB—Rosuvastatin—atherosclerosis	0.0582	0.106	CbGbCtD
Fosphenytoin—CYP2B6—Simvastatin—atherosclerosis	0.0552	0.101	CbGbCtD
Fosphenytoin—CYP2C8—Simvastatin—atherosclerosis	0.0418	0.0762	CbGbCtD
Fosphenytoin—CYP2C8—Pravastatin—atherosclerosis	0.0409	0.0746	CbGbCtD
Fosphenytoin—CYP2C8—Lovastatin—atherosclerosis	0.0409	0.0746	CbGbCtD
Fosphenytoin—CYP2C19—Rosuvastatin—atherosclerosis	0.0377	0.0688	CbGbCtD
Fosphenytoin—CYP2C19—Simvastatin—atherosclerosis	0.0351	0.064	CbGbCtD
Fosphenytoin—CYP2C19—Lovastatin—atherosclerosis	0.0343	0.0626	CbGbCtD
Fosphenytoin—CYP2C9—Rosuvastatin—atherosclerosis	0.0314	0.0572	CbGbCtD
Fosphenytoin—CYP2C9—Simvastatin—atherosclerosis	0.0291	0.0532	CbGbCtD
Fosphenytoin—CYP2C9—Pravastatin—atherosclerosis	0.0285	0.052	CbGbCtD
Fosphenytoin—CYP2C9—Lovastatin—atherosclerosis	0.0285	0.052	CbGbCtD
Fosphenytoin—CYP3A4—Ezetimibe—atherosclerosis	0.0182	0.0333	CbGbCtD
Fosphenytoin—CYP3A4—Rosuvastatin—atherosclerosis	0.0182	0.0333	CbGbCtD
Fosphenytoin—CYP3A4—Simvastatin—atherosclerosis	0.0169	0.0309	CbGbCtD
Fosphenytoin—CYP3A4—Pravastatin—atherosclerosis	0.0166	0.0303	CbGbCtD
Fosphenytoin—CYP3A4—Lovastatin—atherosclerosis	0.0166	0.0303	CbGbCtD
Fosphenytoin—Migraine—Niacin—atherosclerosis	0.000619	0.00461	CcSEcCtD
Fosphenytoin—Affect lability—Pravastatin—atherosclerosis	0.00061	0.00454	CcSEcCtD
Fosphenytoin—Face oedema—Niacin—atherosclerosis	0.000607	0.00452	CcSEcCtD
Fosphenytoin—Gastritis—Simvastatin—atherosclerosis	0.000606	0.00451	CcSEcCtD
Fosphenytoin—Muscular weakness—Simvastatin—atherosclerosis	0.000604	0.0045	CcSEcCtD
Fosphenytoin—Rhinitis—Rosuvastatin—atherosclerosis	0.0006	0.00446	CcSEcCtD
Fosphenytoin—Urinary retention—Niacin—atherosclerosis	0.000598	0.00445	CcSEcCtD
Fosphenytoin—Pharyngitis—Rosuvastatin—atherosclerosis	0.000594	0.00442	CcSEcCtD
Fosphenytoin—Mood swings—Pravastatin—atherosclerosis	0.000587	0.00437	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Niacin—atherosclerosis	0.000581	0.00432	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Lovastatin—atherosclerosis	0.000578	0.0043	CcSEcCtD
Fosphenytoin—Orthostatic hypotension—Niacin—atherosclerosis	0.000575	0.00428	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Pravastatin—atherosclerosis	0.000572	0.00426	CcSEcCtD
Fosphenytoin—Bronchitis—Simvastatin—atherosclerosis	0.00057	0.00424	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.000567	0.00422	CcSEcCtD
Fosphenytoin—Muscular weakness—Niacin—atherosclerosis	0.000555	0.00413	CcSEcCtD
Fosphenytoin—Muscular weakness—Pravastatin—atherosclerosis	0.000546	0.00407	CcSEcCtD
Fosphenytoin—Influenza—Niacin—atherosclerosis	0.000544	0.00405	CcSEcCtD
Fosphenytoin—Dysphagia—Niacin—atherosclerosis	0.000544	0.00405	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Simvastatin—atherosclerosis	0.000541	0.00402	CcSEcCtD
Fosphenytoin—Influenza—Pravastatin—atherosclerosis	0.000535	0.00398	CcSEcCtD
Fosphenytoin—Sinusitis—Lovastatin—atherosclerosis	0.00053	0.00394	CcSEcCtD
Fosphenytoin—Bronchitis—Niacin—atherosclerosis	0.000523	0.00389	CcSEcCtD
Fosphenytoin—Sinusitis—Ezetimibe—atherosclerosis	0.000519	0.00387	CcSEcCtD
Fosphenytoin—Flatulence—Rosuvastatin—atherosclerosis	0.000513	0.00382	CcSEcCtD
Fosphenytoin—Dysuria—Pravastatin—atherosclerosis	0.000501	0.00373	CcSEcCtD
Fosphenytoin—Sinusitis—Simvastatin—atherosclerosis	0.000495	0.00369	CcSEcCtD
Fosphenytoin—Pharyngitis—Ezetimibe—atherosclerosis	0.000493	0.00367	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000489	0.00364	CcSEcCtD
Fosphenytoin—Sweating—Niacin—atherosclerosis	0.000465	0.00346	CcSEcCtD
Fosphenytoin—Chills—Lovastatin—atherosclerosis	0.000455	0.00338	CcSEcCtD
Fosphenytoin—Cough—Rosuvastatin—atherosclerosis	0.000454	0.00338	CcSEcCtD
Fosphenytoin—Sinusitis—Pravastatin—atherosclerosis	0.000448	0.00333	CcSEcCtD
Fosphenytoin—Myalgia—Rosuvastatin—atherosclerosis	0.000443	0.0033	CcSEcCtD
Fosphenytoin—Arthralgia—Rosuvastatin—atherosclerosis	0.000443	0.0033	CcSEcCtD
Fosphenytoin—Rhinitis—Niacin—atherosclerosis	0.000436	0.00325	CcSEcCtD
Fosphenytoin—Flatulence—Lovastatin—atherosclerosis	0.000435	0.00323	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Niacin—atherosclerosis	0.000433	0.00322	CcSEcCtD
Fosphenytoin—Dysgeusia—Lovastatin—atherosclerosis	0.000432	0.00321	CcSEcCtD
Fosphenytoin—Rhinitis—Pravastatin—atherosclerosis	0.00043	0.0032	CcSEcCtD
Fosphenytoin—Confusional state—Rosuvastatin—atherosclerosis	0.000428	0.00319	CcSEcCtD
Fosphenytoin—Back pain—Lovastatin—atherosclerosis	0.000427	0.00318	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Pravastatin—atherosclerosis	0.000426	0.00317	CcSEcCtD
Fosphenytoin—Flatulence—Ezetimibe—atherosclerosis	0.000426	0.00317	CcSEcCtD
Fosphenytoin—Pharyngitis—Pravastatin—atherosclerosis	0.000425	0.00316	CcSEcCtD
Fosphenytoin—Chills—Simvastatin—atherosclerosis	0.000425	0.00316	CcSEcCtD
Fosphenytoin—Muscle spasms—Lovastatin—atherosclerosis	0.000424	0.00316	CcSEcCtD
Fosphenytoin—Infection—Rosuvastatin—atherosclerosis	0.000422	0.00314	CcSEcCtD
Fosphenytoin—Back pain—Ezetimibe—atherosclerosis	0.000419	0.00311	CcSEcCtD
Fosphenytoin—Muscle spasms—Ezetimibe—atherosclerosis	0.000416	0.0031	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000416	0.0031	CcSEcCtD
Fosphenytoin—Tremor—Lovastatin—atherosclerosis	0.000413	0.00308	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Lovastatin—atherosclerosis	0.000409	0.00305	CcSEcCtD
Fosphenytoin—Flatulence—Simvastatin—atherosclerosis	0.000407	0.00303	CcSEcCtD
Fosphenytoin—Tinnitus—Niacin—atherosclerosis	0.000406	0.00302	CcSEcCtD
Fosphenytoin—Dysgeusia—Simvastatin—atherosclerosis	0.000404	0.00301	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000401	0.00299	CcSEcCtD
Fosphenytoin—Anaemia—Ezetimibe—atherosclerosis	0.0004	0.00298	CcSEcCtD
Fosphenytoin—Tinnitus—Pravastatin—atherosclerosis	0.0004	0.00297	CcSEcCtD
Fosphenytoin—Malaise—Lovastatin—atherosclerosis	0.000398	0.00296	CcSEcCtD
Fosphenytoin—Muscle spasms—Simvastatin—atherosclerosis	0.000397	0.00295	CcSEcCtD
Fosphenytoin—Vertigo—Lovastatin—atherosclerosis	0.000396	0.00295	CcSEcCtD
Fosphenytoin—Leukopenia—Lovastatin—atherosclerosis	0.000395	0.00294	CcSEcCtD
Fosphenytoin—Chills—Niacin—atherosclerosis	0.000391	0.00291	CcSEcCtD
Fosphenytoin—Malaise—Ezetimibe—atherosclerosis	0.00039	0.0029	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000387	0.00288	CcSEcCtD
Fosphenytoin—Tremor—Simvastatin—atherosclerosis	0.000387	0.00288	CcSEcCtD
Fosphenytoin—Chills—Pravastatin—atherosclerosis	0.000385	0.00286	CcSEcCtD
Fosphenytoin—Insomnia—Rosuvastatin—atherosclerosis	0.000384	0.00286	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Simvastatin—atherosclerosis	0.000383	0.00285	CcSEcCtD
Fosphenytoin—Palpitations—Ezetimibe—atherosclerosis	0.000382	0.00285	CcSEcCtD
Fosphenytoin—Paraesthesia—Rosuvastatin—atherosclerosis	0.000382	0.00284	CcSEcCtD
Fosphenytoin—Anaemia—Simvastatin—atherosclerosis	0.000381	0.00284	CcSEcCtD
Fosphenytoin—Cough—Ezetimibe—atherosclerosis	0.000378	0.00281	CcSEcCtD
Fosphenytoin—Arthralgia—Lovastatin—atherosclerosis	0.000376	0.00279	CcSEcCtD
Fosphenytoin—Myalgia—Lovastatin—atherosclerosis	0.000376	0.00279	CcSEcCtD
Fosphenytoin—Dyspepsia—Rosuvastatin—atherosclerosis	0.000374	0.00278	CcSEcCtD
Fosphenytoin—Hypertension—Ezetimibe—atherosclerosis	0.000374	0.00278	CcSEcCtD
Fosphenytoin—Flatulence—Niacin—atherosclerosis	0.000373	0.00278	CcSEcCtD
Fosphenytoin—Malaise—Simvastatin—atherosclerosis	0.000372	0.00277	CcSEcCtD
Fosphenytoin—Tension—Niacin—atherosclerosis	0.000372	0.00277	CcSEcCtD
Fosphenytoin—Discomfort—Lovastatin—atherosclerosis	0.000371	0.00276	CcSEcCtD
Fosphenytoin—Vertigo—Simvastatin—atherosclerosis	0.000371	0.00276	CcSEcCtD
Fosphenytoin—Leukopenia—Simvastatin—atherosclerosis	0.000369	0.00275	CcSEcCtD
Fosphenytoin—Arthralgia—Ezetimibe—atherosclerosis	0.000368	0.00274	CcSEcCtD
Fosphenytoin—Myalgia—Ezetimibe—atherosclerosis	0.000368	0.00274	CcSEcCtD
Fosphenytoin—Nervousness—Niacin—atherosclerosis	0.000368	0.00274	CcSEcCtD
Fosphenytoin—Flatulence—Pravastatin—atherosclerosis	0.000368	0.00274	CcSEcCtD
Fosphenytoin—Dry mouth—Lovastatin—atherosclerosis	0.000367	0.00273	CcSEcCtD
Fosphenytoin—Tension—Pravastatin—atherosclerosis	0.000366	0.00272	CcSEcCtD
Fosphenytoin—Dysgeusia—Pravastatin—atherosclerosis	0.000365	0.00272	CcSEcCtD
Fosphenytoin—Muscle spasms—Niacin—atherosclerosis	0.000364	0.00271	CcSEcCtD
Fosphenytoin—Discomfort—Ezetimibe—atherosclerosis	0.000364	0.00271	CcSEcCtD
Fosphenytoin—Constipation—Rosuvastatin—atherosclerosis	0.000363	0.0027	CcSEcCtD
Fosphenytoin—Confusional state—Lovastatin—atherosclerosis	0.000363	0.0027	CcSEcCtD
Fosphenytoin—Nervousness—Pravastatin—atherosclerosis	0.000362	0.0027	CcSEcCtD
Fosphenytoin—Dry mouth—Ezetimibe—atherosclerosis	0.00036	0.00268	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Lovastatin—atherosclerosis	0.00036	0.00268	CcSEcCtD
Fosphenytoin—Muscle spasms—Pravastatin—atherosclerosis	0.000359	0.00267	CcSEcCtD
Fosphenytoin—Infection—Lovastatin—atherosclerosis	0.000358	0.00266	CcSEcCtD
Fosphenytoin—Confusional state—Ezetimibe—atherosclerosis	0.000356	0.00265	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000353	0.00263	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Lovastatin—atherosclerosis	0.000353	0.00262	CcSEcCtD
Fosphenytoin—Myalgia—Simvastatin—atherosclerosis	0.000351	0.00261	CcSEcCtD
Fosphenytoin—Arthralgia—Simvastatin—atherosclerosis	0.000351	0.00261	CcSEcCtD
Fosphenytoin—Infection—Ezetimibe—atherosclerosis	0.000351	0.00261	CcSEcCtD
Fosphenytoin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00035	0.00261	CcSEcCtD
Fosphenytoin—Tremor—Pravastatin—atherosclerosis	0.00035	0.0026	CcSEcCtD
Fosphenytoin—Discomfort—Simvastatin—atherosclerosis	0.000347	0.00258	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Pravastatin—atherosclerosis	0.000346	0.00258	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000346	0.00257	CcSEcCtD
Fosphenytoin—Anaemia—Pravastatin—atherosclerosis	0.000345	0.00257	CcSEcCtD
Fosphenytoin—Anorexia—Lovastatin—atherosclerosis	0.000343	0.00255	CcSEcCtD
Fosphenytoin—Vertigo—Niacin—atherosclerosis	0.00034	0.00253	CcSEcCtD
Fosphenytoin—Syncope—Niacin—atherosclerosis	0.00034	0.00253	CcSEcCtD
Fosphenytoin—Confusional state—Simvastatin—atherosclerosis	0.00034	0.00253	CcSEcCtD
Fosphenytoin—Leukopenia—Niacin—atherosclerosis	0.000339	0.00252	CcSEcCtD
Fosphenytoin—Urticaria—Rosuvastatin—atherosclerosis	0.000338	0.00251	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Simvastatin—atherosclerosis	0.000337	0.00251	CcSEcCtD
Fosphenytoin—Malaise—Pravastatin—atherosclerosis	0.000336	0.0025	CcSEcCtD
Fosphenytoin—Vertigo—Pravastatin—atherosclerosis	0.000335	0.00249	CcSEcCtD
Fosphenytoin—Palpitations—Niacin—atherosclerosis	0.000335	0.00249	CcSEcCtD
Fosphenytoin—Infection—Simvastatin—atherosclerosis	0.000335	0.00249	CcSEcCtD
Fosphenytoin—Leukopenia—Pravastatin—atherosclerosis	0.000334	0.00248	CcSEcCtD
Fosphenytoin—Loss of consciousness—Niacin—atherosclerosis	0.000333	0.00248	CcSEcCtD
Fosphenytoin—Cough—Niacin—atherosclerosis	0.000331	0.00246	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Simvastatin—atherosclerosis	0.00033	0.00245	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000328	0.00244	CcSEcCtD
Fosphenytoin—Insomnia—Lovastatin—atherosclerosis	0.000326	0.00242	CcSEcCtD
Fosphenytoin—Cough—Pravastatin—atherosclerosis	0.000326	0.00242	CcSEcCtD
Fosphenytoin—Paraesthesia—Lovastatin—atherosclerosis	0.000323	0.00241	CcSEcCtD
Fosphenytoin—Myalgia—Niacin—atherosclerosis	0.000323	0.0024	CcSEcCtD
Fosphenytoin—Arthralgia—Niacin—atherosclerosis	0.000323	0.0024	CcSEcCtD
Fosphenytoin—Hypertension—Pravastatin—atherosclerosis	0.000322	0.0024	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000322	0.00239	CcSEcCtD
Fosphenytoin—Anorexia—Simvastatin—atherosclerosis	0.000321	0.00239	CcSEcCtD
Fosphenytoin—Dyspnoea—Lovastatin—atherosclerosis	0.000321	0.00239	CcSEcCtD
Fosphenytoin—Insomnia—Ezetimibe—atherosclerosis	0.000319	0.00238	CcSEcCtD
Fosphenytoin—Arthralgia—Pravastatin—atherosclerosis	0.000318	0.00236	CcSEcCtD
Fosphenytoin—Myalgia—Pravastatin—atherosclerosis	0.000318	0.00236	CcSEcCtD
Fosphenytoin—Paraesthesia—Ezetimibe—atherosclerosis	0.000317	0.00236	CcSEcCtD
Fosphenytoin—Dyspepsia—Lovastatin—atherosclerosis	0.000317	0.00236	CcSEcCtD
Fosphenytoin—Dry mouth—Niacin—atherosclerosis	0.000315	0.00235	CcSEcCtD
Fosphenytoin—Dyspnoea—Ezetimibe—atherosclerosis	0.000315	0.00234	CcSEcCtD
Fosphenytoin—Discomfort—Pravastatin—atherosclerosis	0.000314	0.00234	CcSEcCtD
Fosphenytoin—Decreased appetite—Lovastatin—atherosclerosis	0.000313	0.00233	CcSEcCtD
Fosphenytoin—Dyspepsia—Ezetimibe—atherosclerosis	0.000311	0.00231	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Niacin—atherosclerosis	0.000309	0.0023	CcSEcCtD
Fosphenytoin—Constipation—Lovastatin—atherosclerosis	0.000308	0.00229	CcSEcCtD
Fosphenytoin—Confusional state—Pravastatin—atherosclerosis	0.000307	0.00228	CcSEcCtD
Fosphenytoin—Decreased appetite—Ezetimibe—atherosclerosis	0.000307	0.00228	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000307	0.00228	CcSEcCtD
Fosphenytoin—Asthenia—Rosuvastatin—atherosclerosis	0.000305	0.00227	CcSEcCtD
Fosphenytoin—Insomnia—Simvastatin—atherosclerosis	0.000305	0.00227	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Pravastatin—atherosclerosis	0.000304	0.00227	CcSEcCtD
Fosphenytoin—Shock—Niacin—atherosclerosis	0.000304	0.00226	CcSEcCtD
Fosphenytoin—Infection—Pravastatin—atherosclerosis	0.000302	0.00225	CcSEcCtD
Fosphenytoin—Paraesthesia—Simvastatin—atherosclerosis	0.000302	0.00225	CcSEcCtD
Fosphenytoin—Constipation—Ezetimibe—atherosclerosis	0.000302	0.00225	CcSEcCtD
Fosphenytoin—Tachycardia—Niacin—atherosclerosis	0.000302	0.00225	CcSEcCtD
Fosphenytoin—Pruritus—Rosuvastatin—atherosclerosis	0.000301	0.00224	CcSEcCtD
Fosphenytoin—Dyspnoea—Simvastatin—atherosclerosis	0.0003	0.00223	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Niacin—atherosclerosis	0.000299	0.00222	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Pravastatin—atherosclerosis	0.000298	0.00222	CcSEcCtD
Fosphenytoin—Feeling abnormal—Lovastatin—atherosclerosis	0.000297	0.00221	CcSEcCtD
Fosphenytoin—Dyspepsia—Simvastatin—atherosclerosis	0.000296	0.00221	CcSEcCtD
Fosphenytoin—Anorexia—Niacin—atherosclerosis	0.000295	0.00219	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Pravastatin—atherosclerosis	0.000294	0.00219	CcSEcCtD
Fosphenytoin—Decreased appetite—Simvastatin—atherosclerosis	0.000293	0.00218	CcSEcCtD
Fosphenytoin—Feeling abnormal—Ezetimibe—atherosclerosis	0.000291	0.00217	CcSEcCtD
Fosphenytoin—Diarrhoea—Rosuvastatin—atherosclerosis	0.000291	0.00216	CcSEcCtD
Fosphenytoin—Anorexia—Pravastatin—atherosclerosis	0.00029	0.00216	CcSEcCtD
Fosphenytoin—Hypotension—Niacin—atherosclerosis	0.000289	0.00215	CcSEcCtD
Fosphenytoin—Constipation—Simvastatin—atherosclerosis	0.000288	0.00214	CcSEcCtD
Fosphenytoin—Urticaria—Lovastatin—atherosclerosis	0.000286	0.00213	CcSEcCtD
Fosphenytoin—Body temperature increased—Lovastatin—atherosclerosis	0.000285	0.00212	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000282	0.0021	CcSEcCtD
Fosphenytoin—Dizziness—Rosuvastatin—atherosclerosis	0.000281	0.00209	CcSEcCtD
Fosphenytoin—Urticaria—Ezetimibe—atherosclerosis	0.000281	0.00209	CcSEcCtD
Fosphenytoin—Insomnia—Niacin—atherosclerosis	0.00028	0.00208	CcSEcCtD
Fosphenytoin—Body temperature increased—Ezetimibe—atherosclerosis	0.000279	0.00208	CcSEcCtD
Fosphenytoin—Paraesthesia—Niacin—atherosclerosis	0.000278	0.00207	CcSEcCtD
Fosphenytoin—Feeling abnormal—Simvastatin—atherosclerosis	0.000278	0.00207	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000277	0.00206	CcSEcCtD
Fosphenytoin—Dyspnoea—Niacin—atherosclerosis	0.000276	0.00205	CcSEcCtD
Fosphenytoin—Insomnia—Pravastatin—atherosclerosis	0.000275	0.00205	CcSEcCtD
Fosphenytoin—Somnolence—Niacin—atherosclerosis	0.000275	0.00205	CcSEcCtD
Fosphenytoin—Paraesthesia—Pravastatin—atherosclerosis	0.000273	0.00203	CcSEcCtD
Fosphenytoin—Dyspepsia—Niacin—atherosclerosis	0.000272	0.00203	CcSEcCtD
Fosphenytoin—Dyspnoea—Pravastatin—atherosclerosis	0.000271	0.00202	CcSEcCtD
Fosphenytoin—Decreased appetite—Niacin—atherosclerosis	0.000269	0.002	CcSEcCtD
Fosphenytoin—Dyspepsia—Pravastatin—atherosclerosis	0.000268	0.00199	CcSEcCtD
Fosphenytoin—Rash—Rosuvastatin—atherosclerosis	0.000268	0.00199	CcSEcCtD
Fosphenytoin—Dermatitis—Rosuvastatin—atherosclerosis	0.000268	0.00199	CcSEcCtD
Fosphenytoin—Urticaria—Simvastatin—atherosclerosis	0.000268	0.00199	CcSEcCtD
Fosphenytoin—Body temperature increased—Simvastatin—atherosclerosis	0.000266	0.00198	CcSEcCtD
Fosphenytoin—Headache—Rosuvastatin—atherosclerosis	0.000266	0.00198	CcSEcCtD
Fosphenytoin—Decreased appetite—Pravastatin—atherosclerosis	0.000265	0.00197	CcSEcCtD
Fosphenytoin—Constipation—Pravastatin—atherosclerosis	0.00026	0.00194	CcSEcCtD
Fosphenytoin—Asthenia—Lovastatin—atherosclerosis	0.000258	0.00192	CcSEcCtD
Fosphenytoin—Pruritus—Lovastatin—atherosclerosis	0.000255	0.0019	CcSEcCtD
Fosphenytoin—Asthenia—Ezetimibe—atherosclerosis	0.000253	0.00189	CcSEcCtD
Fosphenytoin—Nausea—Rosuvastatin—atherosclerosis	0.000252	0.00188	CcSEcCtD
Fosphenytoin—Feeling abnormal—Pravastatin—atherosclerosis	0.000251	0.00187	CcSEcCtD
Fosphenytoin—Pruritus—Ezetimibe—atherosclerosis	0.00025	0.00186	CcSEcCtD
Fosphenytoin—Diarrhoea—Lovastatin—atherosclerosis	0.000246	0.00183	CcSEcCtD
Fosphenytoin—Urticaria—Niacin—atherosclerosis	0.000246	0.00183	CcSEcCtD
Fosphenytoin—Body temperature increased—Niacin—atherosclerosis	0.000244	0.00182	CcSEcCtD
Fosphenytoin—Urticaria—Pravastatin—atherosclerosis	0.000242	0.0018	CcSEcCtD
Fosphenytoin—Asthenia—Simvastatin—atherosclerosis	0.000242	0.0018	CcSEcCtD
Fosphenytoin—Diarrhoea—Ezetimibe—atherosclerosis	0.000242	0.0018	CcSEcCtD
Fosphenytoin—Body temperature increased—Pravastatin—atherosclerosis	0.000241	0.00179	CcSEcCtD
Fosphenytoin—Pruritus—Simvastatin—atherosclerosis	0.000238	0.00177	CcSEcCtD
Fosphenytoin—Dizziness—Lovastatin—atherosclerosis	0.000238	0.00177	CcSEcCtD
Fosphenytoin—Dizziness—Ezetimibe—atherosclerosis	0.000234	0.00174	CcSEcCtD
Fosphenytoin—Diarrhoea—Simvastatin—atherosclerosis	0.00023	0.00171	CcSEcCtD
Fosphenytoin—Vomiting—Lovastatin—atherosclerosis	0.000229	0.0017	CcSEcCtD
Fosphenytoin—Rash—Lovastatin—atherosclerosis	0.000227	0.00169	CcSEcCtD
Fosphenytoin—Dermatitis—Lovastatin—atherosclerosis	0.000227	0.00169	CcSEcCtD
Fosphenytoin—Headache—Lovastatin—atherosclerosis	0.000226	0.00168	CcSEcCtD
Fosphenytoin—Vomiting—Ezetimibe—atherosclerosis	0.000225	0.00167	CcSEcCtD
Fosphenytoin—Dizziness—Simvastatin—atherosclerosis	0.000223	0.00166	CcSEcCtD
Fosphenytoin—Rash—Ezetimibe—atherosclerosis	0.000223	0.00166	CcSEcCtD
Fosphenytoin—Dermatitis—Ezetimibe—atherosclerosis	0.000222	0.00166	CcSEcCtD
Fosphenytoin—Asthenia—Niacin—atherosclerosis	0.000222	0.00165	CcSEcCtD
Fosphenytoin—Headache—Ezetimibe—atherosclerosis	0.000221	0.00165	CcSEcCtD
Fosphenytoin—Pruritus—Niacin—atherosclerosis	0.000219	0.00163	CcSEcCtD
Fosphenytoin—Asthenia—Pravastatin—atherosclerosis	0.000218	0.00163	CcSEcCtD
Fosphenytoin—Pruritus—Pravastatin—atherosclerosis	0.000215	0.0016	CcSEcCtD
Fosphenytoin—Vomiting—Simvastatin—atherosclerosis	0.000214	0.00159	CcSEcCtD
Fosphenytoin—Nausea—Lovastatin—atherosclerosis	0.000214	0.00159	CcSEcCtD
Fosphenytoin—Rash—Simvastatin—atherosclerosis	0.000212	0.00158	CcSEcCtD
Fosphenytoin—Dermatitis—Simvastatin—atherosclerosis	0.000212	0.00158	CcSEcCtD
Fosphenytoin—Diarrhoea—Niacin—atherosclerosis	0.000212	0.00157	CcSEcCtD
Fosphenytoin—Headache—Simvastatin—atherosclerosis	0.000211	0.00157	CcSEcCtD
Fosphenytoin—Nausea—Ezetimibe—atherosclerosis	0.00021	0.00156	CcSEcCtD
Fosphenytoin—Diarrhoea—Pravastatin—atherosclerosis	0.000208	0.00155	CcSEcCtD
Fosphenytoin—Dizziness—Niacin—atherosclerosis	0.000204	0.00152	CcSEcCtD
Fosphenytoin—Dizziness—Pravastatin—atherosclerosis	0.000201	0.0015	CcSEcCtD
Fosphenytoin—Nausea—Simvastatin—atherosclerosis	0.0002	0.00149	CcSEcCtD
Fosphenytoin—Vomiting—Niacin—atherosclerosis	0.000197	0.00146	CcSEcCtD
Fosphenytoin—Rash—Niacin—atherosclerosis	0.000195	0.00145	CcSEcCtD
Fosphenytoin—Dermatitis—Niacin—atherosclerosis	0.000195	0.00145	CcSEcCtD
Fosphenytoin—Headache—Niacin—atherosclerosis	0.000194	0.00144	CcSEcCtD
Fosphenytoin—Vomiting—Pravastatin—atherosclerosis	0.000194	0.00144	CcSEcCtD
Fosphenytoin—Rash—Pravastatin—atherosclerosis	0.000192	0.00143	CcSEcCtD
Fosphenytoin—Dermatitis—Pravastatin—atherosclerosis	0.000192	0.00143	CcSEcCtD
Fosphenytoin—Headache—Pravastatin—atherosclerosis	0.000191	0.00142	CcSEcCtD
Fosphenytoin—Nausea—Niacin—atherosclerosis	0.000184	0.00137	CcSEcCtD
Fosphenytoin—Nausea—Pravastatin—atherosclerosis	0.000181	0.00135	CcSEcCtD
Fosphenytoin—CYP2C19—Metabolism—ALOX5AP—atherosclerosis	1.66e-05	0.000218	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—APOC3—atherosclerosis	1.66e-05	0.000217	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.66e-05	0.000217	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—NOS2—atherosclerosis	1.65e-05	0.000217	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.65e-05	0.000216	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—AKT1—atherosclerosis	1.65e-05	0.000216	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—LDLR—atherosclerosis	1.65e-05	0.000216	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.65e-05	0.000216	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ABCG5—atherosclerosis	1.64e-05	0.000215	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.64e-05	0.000215	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	1.64e-05	0.000215	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PLA2G1B—atherosclerosis	1.63e-05	0.000214	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.62e-05	0.000213	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.62e-05	0.000212	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.61e-05	0.000212	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CETP—atherosclerosis	1.61e-05	0.000211	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.61e-05	0.000211	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.6e-05	0.00021	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP27A1—atherosclerosis	1.6e-05	0.00021	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PIK3CG—atherosclerosis	1.6e-05	0.00021	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.6e-05	0.00021	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.6e-05	0.000209	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.59e-05	0.000209	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.59e-05	0.000209	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—LPA—atherosclerosis	1.59e-05	0.000208	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ALOX5—atherosclerosis	1.59e-05	0.000208	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ALOX5—atherosclerosis	1.58e-05	0.000207	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.58e-05	0.000207	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—SCARB1—atherosclerosis	1.54e-05	0.000202	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—BGN—atherosclerosis	1.54e-05	0.000202	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.54e-05	0.000202	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.53e-05	0.0002	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—APOA5—atherosclerosis	1.52e-05	0.0002	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.52e-05	0.000199	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.52e-05	0.000199	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—APOA2—atherosclerosis	1.52e-05	0.000199	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.52e-05	0.000199	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.52e-05	0.000199	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.5e-05	0.000196	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.5e-05	0.000196	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.48e-05	0.000194	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	1.47e-05	0.000192	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.46e-05	0.000192	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—IGF1—atherosclerosis	1.46e-05	0.000192	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.46e-05	0.000191	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—HMGCR—atherosclerosis	1.46e-05	0.000191	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.45e-05	0.00019	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—LPA—atherosclerosis	1.45e-05	0.00019	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.44e-05	0.000188	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.43e-05	0.000188	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—NAMPT—atherosclerosis	1.42e-05	0.000186	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ALOX5—atherosclerosis	1.42e-05	0.000185	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—NAMPT—atherosclerosis	1.41e-05	0.000185	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.41e-05	0.000185	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—LIPC—atherosclerosis	1.41e-05	0.000185	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.41e-05	0.000184	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—LIPC—atherosclerosis	1.41e-05	0.000184	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—APOC3—atherosclerosis	1.4e-05	0.000184	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—BGN—atherosclerosis	1.4e-05	0.000184	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—APOC3—atherosclerosis	1.4e-05	0.000183	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—LDLR—atherosclerosis	1.4e-05	0.000183	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.39e-05	0.000182	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—SERPINE1—atherosclerosis	1.39e-05	0.000182	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—APOA5—atherosclerosis	1.39e-05	0.000182	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—LDLR—atherosclerosis	1.39e-05	0.000182	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CETP—atherosclerosis	1.36e-05	0.000179	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CETP—atherosclerosis	1.36e-05	0.000178	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.35e-05	0.000177	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.34e-05	0.000175	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—NOS3—atherosclerosis	1.33e-05	0.000174	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.32e-05	0.000173	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.31e-05	0.000172	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.31e-05	0.000171	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.31e-05	0.000171	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—SCARB1—atherosclerosis	1.31e-05	0.000171	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—SCARB1—atherosclerosis	1.3e-05	0.00017	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ABCA1—atherosclerosis	1.3e-05	0.00017	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.29e-05	0.000169	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.27e-05	0.000167	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.27e-05	0.000166	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.26e-05	0.000165	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—LIPC—atherosclerosis	1.26e-05	0.000165	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.26e-05	0.000165	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—APOC3—atherosclerosis	1.25e-05	0.000164	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—LDLR—atherosclerosis	1.25e-05	0.000163	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—HMGCR—atherosclerosis	1.23e-05	0.000162	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—HMGCR—atherosclerosis	1.23e-05	0.000161	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CETP—atherosclerosis	1.22e-05	0.00016	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.19e-05	0.000156	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—LCAT—atherosclerosis	1.18e-05	0.000155	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—FABP4—atherosclerosis	1.18e-05	0.000155	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	1.18e-05	0.000155	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.17e-05	0.000153	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—APOA4—atherosclerosis	1.16e-05	0.000152	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.16e-05	0.000152	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.15e-05	0.000151	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—LIPC—atherosclerosis	1.15e-05	0.000151	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—APOC3—atherosclerosis	1.14e-05	0.00015	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.14e-05	0.00015	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—LDLR—atherosclerosis	1.14e-05	0.000149	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.13e-05	0.000149	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—HMOX1—atherosclerosis	1.11e-05	0.000146	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.11e-05	0.000146	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CETP—atherosclerosis	1.11e-05	0.000145	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.11e-05	0.000145	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.1e-05	0.000144	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ABCA1—atherosclerosis	1.1e-05	0.000144	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ABCA1—atherosclerosis	1.09e-05	0.000143	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—APOB—atherosclerosis	1.07e-05	0.00014	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.06e-05	0.000139	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.06e-05	0.000138	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTM1—atherosclerosis	1.04e-05	0.000136	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.03e-05	0.000136	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—LPL—atherosclerosis	1.02e-05	0.000134	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—HMGCR—atherosclerosis	1e-05	0.000132	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1e-05	0.000131	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—APOA2—atherosclerosis	1e-05	0.000131	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ALOX15—atherosclerosis	1e-05	0.000131	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1e-05	0.000131	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GPX1—atherosclerosis	9.94e-06	0.00013	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.93e-06	0.00013	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ABCG5—atherosclerosis	9.89e-06	0.00013	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ABCA1—atherosclerosis	9.81e-06	0.000129	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CD36—atherosclerosis	9.68e-06	0.000127	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—VEGFA—atherosclerosis	9.57e-06	0.000125	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—LPA—atherosclerosis	9.55e-06	0.000125	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—HMOX1—atherosclerosis	9.43e-06	0.000124	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—HMOX1—atherosclerosis	9.38e-06	0.000123	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—BGN—atherosclerosis	9.25e-06	0.000121	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—MTHFR—atherosclerosis	9.17e-06	0.00012	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—APOA5—atherosclerosis	9.15e-06	0.00012	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.05e-06	0.000119	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—MAPK3—atherosclerosis	9.05e-06	0.000119	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—APOB—atherosclerosis	9.03e-06	0.000118	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PPARA—atherosclerosis	9e-06	0.000118	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—APOB—atherosclerosis	8.98e-06	0.000118	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ABCA1—atherosclerosis	8.94e-06	0.000117	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	8.81e-06	0.000115	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTM1—atherosclerosis	8.79e-06	0.000115	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—TGFB1—atherosclerosis	8.78e-06	0.000115	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTM1—atherosclerosis	8.74e-06	0.000115	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—AGT—atherosclerosis	8.71e-06	0.000114	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—LPL—atherosclerosis	8.62e-06	0.000113	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—LPL—atherosclerosis	8.57e-06	0.000112	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—APOE—atherosclerosis	8.54e-06	0.000112	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ALOX5—atherosclerosis	8.51e-06	0.000112	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CAV1—atherosclerosis	8.46e-06	0.000111	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—APOA1—atherosclerosis	8.44e-06	0.000111	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—HMOX1—atherosclerosis	8.42e-06	0.00011	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GPX1—atherosclerosis	8.41e-06	0.00011	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GPX1—atherosclerosis	8.37e-06	0.00011	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CD36—atherosclerosis	8.19e-06	0.000107	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CD36—atherosclerosis	8.15e-06	0.000107	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—APOB—atherosclerosis	8.06e-06	0.000106	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTM1—atherosclerosis	7.84e-06	0.000103	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—MTHFR—atherosclerosis	7.76e-06	0.000102	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—MTHFR—atherosclerosis	7.72e-06	0.000101	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CG—atherosclerosis	7.71e-06	0.000101	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—LPL—atherosclerosis	7.7e-06	0.000101	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—HMOX1—atherosclerosis	7.67e-06	0.000101	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NAMPT—atherosclerosis	7.63e-06	0.0001	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PPARA—atherosclerosis	7.62e-06	9.98e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—LIPC—atherosclerosis	7.59e-06	9.94e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PPARA—atherosclerosis	7.57e-06	9.93e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—APOC3—atherosclerosis	7.54e-06	9.88e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GPX1—atherosclerosis	7.51e-06	9.84e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—LDLR—atherosclerosis	7.49e-06	9.82e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PPARG—atherosclerosis	7.44e-06	9.75e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—AGT—atherosclerosis	7.38e-06	9.67e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—APOB—atherosclerosis	7.35e-06	9.63e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—AGT—atherosclerosis	7.34e-06	9.61e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CETP—atherosclerosis	7.32e-06	9.59e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CD36—atherosclerosis	7.31e-06	9.59e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—INS—atherosclerosis	7.29e-06	9.56e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—APOE—atherosclerosis	7.23e-06	9.47e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—APOE—atherosclerosis	7.19e-06	9.42e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CAV1—atherosclerosis	7.16e-06	9.39e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTM1—atherosclerosis	7.15e-06	9.37e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—APOA1—atherosclerosis	7.15e-06	9.37e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CAV1—atherosclerosis	7.12e-06	9.33e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—APOA1—atherosclerosis	7.11e-06	9.31e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—LPL—atherosclerosis	7.02e-06	9.2e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—SCARB1—atherosclerosis	7.01e-06	9.19e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—MTHFR—atherosclerosis	6.93e-06	9.08e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GPX1—atherosclerosis	6.85e-06	8.98e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PPARA—atherosclerosis	6.8e-06	8.91e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ALB—atherosclerosis	6.69e-06	8.77e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CD36—atherosclerosis	6.67e-06	8.74e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—HMGCR—atherosclerosis	6.62e-06	8.67e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—AGT—atherosclerosis	6.59e-06	8.63e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CG—atherosclerosis	6.52e-06	8.55e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CG—atherosclerosis	6.49e-06	8.5e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—APOE—atherosclerosis	6.45e-06	8.46e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—NOS3—atherosclerosis	6.4e-06	8.38e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CAV1—atherosclerosis	6.39e-06	8.38e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—APOA1—atherosclerosis	6.38e-06	8.36e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—MTHFR—atherosclerosis	6.32e-06	8.28e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PPARG—atherosclerosis	6.3e-06	8.25e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PPARG—atherosclerosis	6.26e-06	8.21e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PPARA—atherosclerosis	6.2e-06	8.13e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—INS—atherosclerosis	6.18e-06	8.09e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—INS—atherosclerosis	6.14e-06	8.05e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—AKT1—atherosclerosis	6.11e-06	8e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—AGT—atherosclerosis	6e-06	7.87e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.9e-06	7.73e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—APOE—atherosclerosis	5.88e-06	7.71e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PTGS2—atherosclerosis	5.85e-06	7.67e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CAV1—atherosclerosis	5.83e-06	7.64e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CG—atherosclerosis	5.82e-06	7.63e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—APOA1—atherosclerosis	5.82e-06	7.62e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ALB—atherosclerosis	5.66e-06	7.42e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PPARG—atherosclerosis	5.62e-06	7.37e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—INS—atherosclerosis	5.51e-06	7.22e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—NOS3—atherosclerosis	5.42e-06	7.1e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—NOS3—atherosclerosis	5.38e-06	7.06e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CG—atherosclerosis	5.31e-06	6.96e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PPARG—atherosclerosis	5.12e-06	6.72e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.06e-06	6.63e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ALB—atherosclerosis	5.05e-06	6.62e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—INS—atherosclerosis	5.03e-06	6.59e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PTGS2—atherosclerosis	4.95e-06	6.49e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PTGS2—atherosclerosis	4.92e-06	6.46e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—APOB—atherosclerosis	4.85e-06	6.35e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NOS3—atherosclerosis	4.83e-06	6.34e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.72e-06	6.18e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—LPL—atherosclerosis	4.63e-06	6.07e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ALB—atherosclerosis	4.61e-06	6.04e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GPX1—atherosclerosis	4.52e-06	5.92e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PTGS2—atherosclerosis	4.42e-06	5.79e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NOS3—atherosclerosis	4.41e-06	5.78e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CD36—atherosclerosis	4.4e-06	5.76e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.17e-06	5.46e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PPARA—atherosclerosis	4.09e-06	5.36e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PTGS2—atherosclerosis	4.03e-06	5.28e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—AGT—atherosclerosis	3.96e-06	5.19e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—APOE—atherosclerosis	3.88e-06	5.09e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CAV1—atherosclerosis	3.84e-06	5.04e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—APOA1—atherosclerosis	3.84e-06	5.03e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.5e-06	4.59e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PPARG—atherosclerosis	3.38e-06	4.43e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—INS—atherosclerosis	3.31e-06	4.34e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ALB—atherosclerosis	3.04e-06	3.98e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—AKT1—atherosclerosis	2.94e-06	3.85e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NOS3—atherosclerosis	2.91e-06	3.81e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.66e-06	3.48e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—AKT1—atherosclerosis	2.49e-06	3.26e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—AKT1—atherosclerosis	2.48e-06	3.24e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—AKT1—atherosclerosis	2.22e-06	2.91e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—AKT1—atherosclerosis	2.03e-06	2.66e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—AKT1—atherosclerosis	1.34e-06	1.75e-05	CbGpPWpGaD
